British rock icons Oasis began their long-awaited reunion tour this month, and it's not hard to see parallels between the ...

Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...

Markets reflect a widespread belief that the US president always chickens out on trade measures. AstraZeneca’s plan to invest ...

Oppenheimer initiated coverage of the buy now, pay later firm Monday, issuing an "outperform" rating for Affirm stock.

In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

Paul Walsh, founder and managing partner of Walsh Barnes, is winding down his practice after 35 years to launch his own ...

Morgan Stanley poached Aftab Shahsingh from UBS to spearhead industrial services coverage. Shahsingh brings over 15 years of ...